Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K-CREATE Study.

Helicobacter - 1 Jan 2000

Kim Joon Sung, Kim Byung-Wook, Kim Jin Il, Chung Woo Chul, Jung Sung Woo, Bang Chang Seok, Kim Gwang Ha, Jeon Seon Woo, Joo Moon Kyoung, Lee Si Hyung, Lim Yun Jeong, Sung Jae Kyu, Seo Seung Young, Park Sun Young, Lee Wan Sik, Lee Hang Lak, Kim Ki Bae, Kim Heung Up

Abstract excerpt

BACKGROUND: The optimal duration of regimens for tailored therapy based on genotypic resistance for clarithromycin has yet to be established. AIM: This study was a nationwide, multicenter, randomized trial comparing empirical therapy with tailored therapy based on genotypic resistance for first-line eradication of Helicobacter pylori. We also compared the eradication rates of 7- and 14-day regimens for each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amoxicillin
Share to Clarithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Drug Therapy, Combination

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Metronidazole

Share to Republic of Korea

Source

Identifiers

PMID: 39143948
DOI: 10.1111/hel.13126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K-CREATE Study.PMID 39143948Read ↗

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.Semantic proximity Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.Semantic proximity Read ↗

[Minocycline quadruple versus tailored therapy in retreatment of Helicobacter pylori infection].Semantic proximity Read ↗

Treatment of Helicobacter pylori infection: Where are we now?Semantic proximity Read ↗

Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.Semantic proximity Read ↗

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Semantic proximity Read ↗

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.Semantic proximity Read ↗

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read ↗

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Semantic proximity Read ↗

Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.Semantic proximity Read ↗

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.